OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Opicapone in Uk Clinical Practice: effectiveness, Safety and Cost Analysis in Patients With Parkinson’s Disease
Christine Schofield, К. Ray Chaudhuri, Camille Carroll, et al.
Neurodegenerative Disease Management (2022) Vol. 12, Iss. 2, pp. 77-91
Open Access | Times Cited: 5
Christine Schofield, К. Ray Chaudhuri, Camille Carroll, et al.
Neurodegenerative Disease Management (2022) Vol. 12, Iss. 2, pp. 77-91
Open Access | Times Cited: 5
Showing 5 citing articles:
The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone
Valentina Leta, Daniel J. van Wamelen, Federico Aureli, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 7, pp. 925-930
Open Access | Times Cited: 4
Valentina Leta, Daniel J. van Wamelen, Federico Aureli, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 7, pp. 925-930
Open Access | Times Cited: 4
Opicapone versus entacapone: Head‐to‐head retrospective data‐based comparison of healthcare resource utilization in people with Parkinson's disease new to catechol‐O‐methyltransferase (COMT) inhibitor treatment
Glynn Harrison‐Jones, Xiaocong Li Marston, Francesca Morgante, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 10, pp. 3132-3141
Open Access | Times Cited: 4
Glynn Harrison‐Jones, Xiaocong Li Marston, Francesca Morgante, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 10, pp. 3132-3141
Open Access | Times Cited: 4
Can Continuous Levodopa Delivery Be Achieved in the Absence of Intrajejunal Levodopa Infusion? Implications for India and Underserved Countries
К. Ray Chaudhuri, Lucia Batzu
Movement Disorders Clinical Practice (2023) Vol. 11, Iss. 1, pp. 21-29
Open Access | Times Cited: 2
К. Ray Chaudhuri, Lucia Batzu
Movement Disorders Clinical Practice (2023) Vol. 11, Iss. 1, pp. 21-29
Open Access | Times Cited: 2
Adverse event profiles of adjuvant treatment with opicapone in Parkinson’s disease: A systematic review and meta-analysis
Luwen Xie, Xiaoyi Qi, Xuan Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Luwen Xie, Xiaoyi Qi, Xuan Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Disease Stage and Motor Fluctuation Duration Predict Drug Tolerability: A Real-Life, Prospective Italian Multicenter Study on the Use of Opicapone in Parkinson’s Disease
Ruggero Bacchin, Marco Liccari, Mauro Catalan, et al.
Drugs - Real World Outcomes (2024) Vol. 11, Iss. 3, pp. 361-368
Open Access
Ruggero Bacchin, Marco Liccari, Mauro Catalan, et al.
Drugs - Real World Outcomes (2024) Vol. 11, Iss. 3, pp. 361-368
Open Access
